2024 |
Camp, E., Garcia, L. G., Pribadi, C., Paton, S., Vasilev, K., Anderson, P., & Gronthos, S. (2024). Targeting of C-ROS-1 Activity Using a Controlled Release Carrier to Treat Craniosynostosis in a Preclinical Model of Saethre-Chotzen Syndrome. Journal of Tissue Engineering and Regenerative Medicine, 2024, 8863925-1-8863925-12. DOI |
2024 |
Campbell, J. M., Habibalahi, A., Agha, A., Handley, S., Knab, A., Xu, X., . . . Goldys, E. M. (2024). Single cell, Label free Characterisation of Human Mesenchymal Stromal cell Stemness and Future Growth Potential by Autofluorescence Multispectral Imaging. Stem Cell Reviews and Reports, 10 pages. DOI |
2024 |
Campbell, J. M., Mahbub, S. B., Anwer, A. G., Habibalahi, A., Gronthos, S., Paton, S., . . . Goldys, E. M. (2024). Multispectral Imaging of Collagen, NAD(P)H and Flavin Autofluorescence in Mesenchymal Stem Cells Undergoing Trilineage Differentiation.. Cells, 13(20), 1731. DOI |
2022 |
Kutyna, M. M., Kok, C. H., Lim, Y., Campbell, D., Paton, S., Thompson-Peach, C. A. L., . . . Hiwase, D. (2022). Senolytic Therapy Can Reverse Senescent Bone Marrow Stroma of Therapy-Related Myeloid Neoplasm. Blood, 140(Supplement 1), 9755-9756. DOI |
2022 |
Kutyna, M. M., Kok, C. H., Lim, Y., Tran, E. N. H., Campbell, D., Paton, S., . . . Hiwase, D. K. (2022). A senescence stress secretome is a hallmark of therapy-related myeloid neoplasm stromal tissue occurring soon after cytotoxic exposure. Leukemia, 36(11), 2678-2689. DOI Scopus12 WoS4 Europe PMC10 |
2021 |
Campbell, J. M., Mahbub, S., Habibalahi, A., Paton, S., Gronthos, S., & Goldys, E. (2021). Ageing human bone marrow mesenchymal stem cells have depleted NAD(P)H and distinct multispectral autofluorescence. GeroScience, 43(2), 859-868. DOI Scopus11 WoS10 Europe PMC9 |
2020 |
Arthur, A., Paton, S., Zannettino, A. C. W., & Gronthos, S. (2020). Conditional knockout of ephrinB1 in osteogenic progenitors delays the process of endochondral ossification during fracture repair. Bone, 132, 115189-1-115189-10. DOI Scopus9 WoS7 Europe PMC5 |
2020 |
Kutyna, M. M., Wee, L. Y. A., Paton, S., Cakouros, D., Arthur, A., Chhetri, R., . . . Hiwase, D. K. (2020). Therapy-Related Myeloid Neoplasm Has a Distinct Pro-Inflammatory Bone Marrow Microenvironment and Delayed DNA Damage Repair. Blood, 136(Supplement 1), 37-38. DOI |
2019 |
Arthur, A., Nguyen, T. M., Paton, S., Zannettino, A. C. W., & Gronthos, S. (2019). Loss of EfnB1 in the osteogenic lineage compromises their capacity to support hematopoietic stem/progenitor cell maintenance. Experimental Hematology, 69, 43-53. DOI Scopus14 WoS13 Europe PMC10 |
2019 |
Campbell, J. M., Habibalahi, A., Mahbub, S., Gosnell, M., Anwer, A. G., Paton, S., . . . Goldys, E. (2019). Non-destructive, label free identification of cell cycle phase in cancer cells by multispectral microscopy of autofluorescence. BMC Cancer, 19(1), 1-11. DOI Scopus20 WoS16 Europe PMC13 |
2018 |
Arthur, A., Nguyen, T., Paton, S., Klisuric, A., Zannettino, A., & Gronthos, S. (2018). The osteoprogenitor-specific loss of ephrinB1 results in an osteoporotic phenotype affecting the balance between bone formation and resorption. Scientific Reports, 8(1), 12756-1-12756-12. DOI Scopus14 WoS11 Europe PMC6 |
2017 |
Wu, J., Shimmon, S., Paton, S., Daly, C., Goldschlager, T., Gronthos, S., . . . Ghosh, P. (2017). Pentosan polysulfate binds to STRO-1+mesenchymal progenitor cells, is internalized, and modifies gene expression: A novel approach of pre-programing stem cells for therapeutic application requiring their chondrogenesis. Stem Cell Research and Therapy, 8(1), 15 pages. DOI Scopus8 WoS8 Europe PMC6 |
2016 |
Nguyen, T., Arthur, A., Paton, S., Hemming, S., Panagopoulos, R., Codrington, J., . . . Gronthos, S. (2016). Loss of ephrinB1 in osteogenic progenitor cells impedes endochondral ossification and compromises bone strength integrity during skeletal development. Bone, 93, 12-21. DOI Scopus18 WoS17 Europe PMC12 |
2015 |
Nguyen, T., Arthur, A., Panagopoulos, R., Paton, S., Hayball, J., Zannettino, A., . . . Gronthos, S. (2015). EphB4 expressing stromal cells exhibit an enhanced capacity for hematopoietic stem cell maintenance. Stem Cells, 33(9), 2838-2849. DOI Scopus28 WoS26 Europe PMC21 |
2014 |
Richardson, J., Psaltis, P., Frost, L., Paton, S., Carbone, A., Bertaso, A., . . . Worthley, S. (2014). Incremental benefits of repeated mesenchymal stromal cell administration compared with solitary intervention after myocardial infarction. Cytotherapy, 16(4), 460-470. DOI Scopus21 WoS21 Europe PMC16 |
2013 |
Richardson, J., Bertaso, A., Frost, L., Psaltis, P., Carbone, A., Koschade, B., . . . Worthley, S. (2013). Cardiac magnetic resonance, transthoracic and transoesophageal echocardiography: a comparison of invivo assessment of ventricular function in rats. Laboratory Animals, 47(4), 291-300. DOI Scopus7 WoS6 Europe PMC4 |
2013 |
Richardson, J., Bertaso, A., Psaltis, P., Frost, L., Carbone, A., Paton, S., . . . Worthley, S. (2013). Impact of timing and dose of mesenchymal stromal cell therapy in a preclinical model of acute myocardial infarction. Journal of Cardiac Failure, 19(5), 342-353. DOI Scopus45 WoS41 Europe PMC30 |
2012 |
Richardson, J., Frost, L., Bertaso, A., Carbone, A., Paton, S., Nelson, A., . . . Worthley, S. (2012). Sequential Mesenchymal Stem Cell Interventions Produce Greater Myocardial Repair than Solitary Treatment in Rats After Acute Myocardial Infarction. Heart, Lung and Circulation, 21, S92-S93. DOI |
2012 |
Richardson, J., Paton, S., Frost, L., Carbone, A., Bertaso, A., Nelson, A., . . . Worthley, S. (2012). Prospectively Isolated, Hypoxic-Preconditioned Mesenchymal Stem Cells Significantly Attenuate Myocardial Infarction-Induced Ventricular Dysfunction In Rats. Heart, Lung and Circulation, 21, S90. DOI |
2012 |
Richardson, J., Frost, L., Bertaso, A., Carbone, A., Paton, S., Nelson, A., . . . Worthley, S. (2012). Immediate Mesenchymal Stem Cell Therapy Provides Greater Attenuation of Myocardial Injury Than Deferred Treatment in Rats After Acute Myocardial Infarction. Heart, Lung and Circulation, 21, S2. DOI |
2010 |
Zannettino, A., Paton, S., Itescu, S., & Gronthos, S. (2010). Comparative assessment of the osteoconductive properties of different biomaterials in vivo seeded with human or ovine mesenchymal stem/stromal cells. Tissue Engineering. Part A. Tissue Engineering, 16(12), 3579-3587. DOI Scopus32 WoS29 Europe PMC23 |
2010 |
Psaltis, P., Paton, S., See, F., Arthur, A., Martin, S., Itescu, S., . . . Zannettino, A. (2010). Enrichment for STRO-1 expression enhances the cardiovascular paracrine activity of human bone marrow-derived mesenchymal cell populations. Journal of Cellular Physiology, 223(2), 530-540. DOI Scopus128 WoS115 Europe PMC92 |
2009 |
Gronthos, S., McCarty, R., Mrozik, K., Fitter, S., Paton, S., Menicanin, D., . . . Zannettino, A. (2009). Heat shock protein-90 beta is expressed at the surface of multipotential mesenchymal precursor cells: Generation of a novel monoclonal antibody, STRO-4, with specificity for mesenchymal precursor cells from human and ovine tissues. Stem Cells and Development, 18(9), 1253-1261. DOI Scopus71 WoS61 Europe PMC45 |
2009 |
Psaltis, P. J., See, F., Paton, S., Martens, T. P., Itescu, S., Worthley, S. G., . . . Zannettino, A. C. W. (2009). STRO-1 immunoselection enhances the biological properties and cardiovascular paracrine effects of bone marrow mesenchymal stromal cells. EUROPEAN HEART JOURNAL, 30, 501. |
2008 |
Zannettino, A., Paton, S., Kortesidis, A., Khor, F., Itescu, S., & Gronthos, S. (2008). Human mulipotential mesenchymal/stromal stem cells are derived from a discrete subpopulation of STRO-1bright/CD34-/CD45-/glycophorin-A-bone marrow cells. Haematologica, 92(12), 1707-1708. DOI Scopus75 WoS66 Europe PMC49 |
2008 |
Zannettino, A., Paton, S., Arthur, A., Khor, F., Itescu, S., Gimble, J., & Gronthos, S. (2008). Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. Journal of Cellular Physiology, 214(2), 413-421. DOI Scopus481 WoS417 Europe PMC341 |
1997 |
Kaur, P., Paton, S., Furze, J., Wrin, J., Olsen, S., Danks, J., & Scurry, J. (1997). Identification of a cell surface protein with a role in stimulating human keratinocyte proliferation, expressed during development and carcinogenesis. Journal of Investigative Dermatology, 109(2), 194-199. DOI Scopus7 WoS7 Europe PMC7 |
1996 |
Kaur, P., Paton, S., Furze, J., & Wrin, J. (1996). Identification of a cell surface molecule associated with proliferation during development and carcinogenesis in human keratinocytes.. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 107(3), 155. |